Home
About
Overview
Sharing Data
ORCID
Help
History (19)
The effects of brain death and ischemia on tolerance induction are organ-specific.
Cherchi, Marcello
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers.
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers. Clin Liver Dis. 2023 05; 27(2):251-273.
View in:
PubMed
subject areas
Diabetes Mellitus, Type 2
Humans
Liver
Liver Cirrhosis
Metabolic Syndrome
Neoplasms
Non-alcoholic Fatty Liver Disease
authors with profiles
Mary Rinella